Distribution of the microtubule-related protein ninein in developing neurons

Ninein associates with the centrosome in many cell types, where it recaptures minus-ends of microtubules after their release. In more complex and polarized cells, ninein has also been observed at noncentrosomal locales, where its function is not as well understood. We have found that cultured neuron...

Full description

Saved in:
Bibliographic Details
Published inNeuropharmacology Vol. 47; no. 5; pp. 677 - 683
Main Authors Baird, Douglas H., Myers, Kenneth A., Mogensen, Mette, Moss, David, Baas, Peter W.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Ninein associates with the centrosome in many cell types, where it recaptures minus-ends of microtubules after their release. In more complex and polarized cells, ninein has also been observed at noncentrosomal locales, where its function is not as well understood. We have found that cultured neurons contain both centrosomal and noncentrosomal ninein, and that the noncentrosomal ninein, typically observed as small particles, is both abundant and widespread. Noncentrosomal ninein is also dispersed throughout the cytoplasm of non-neuronal cells present within the cultures, but is particularly rich in the cytoplasm of neurons, where it may compete with centrosomal ninein to impede the recapture of microtubules by the centrosome after their release. Interestingly, noncentrosomal ninein is concentrated in regions of both neurons and non-neuronal cells undergoing retraction, such as in the trailing processes that retract during neuronal migration. These results suggest that noncentrosomal ninein may contribute to the configuration of the microtubule array underlying alterations in cellular morphology, and that such a contribution is likely to be particularly important for neuronal cells.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0028-3908
1873-7064
DOI:10.1016/j.neuropharm.2004.07.016